Stockscreener 앱 받기
10.91
1.99%
0.2293
Bioventus Inc 주식(BVS)의 최신 뉴스
Bioventus (NASDAQ:BVS) Reaches New 1-Year High on Better-Than-Expected Earnings - MarketBeat
Bioventus Q1 Earnings Call Highlights - Yahoo Finance
Bioventus Q1 2026 slides: earnings beat drives guidance raise - Investing.com
Bioventus Inc. Reports Earnings Results for the First Quarter Ended March 28, 2026 - marketscreener.com
Earnings call transcript: Bioventus beats Q1 2026 forecasts, stock rises By Investing.com - Investing.com Canada
Bioventus (BVS) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance
Bioventus : Q1'26 Earnings Call Slides - marketscreener.com
Bioventus Inc (NASDAQ:BVS) Smashes Q1 Estimates and Lifts Guidance, Shares Rally - ChartMill
Bioventus (NASDAQ:BVS) Updates FY 2026 Earnings Guidance - MarketBeat
[10-Q] Bioventus Inc. Quarterly Earnings Report - Stock Titan
Bioventus (BVS) lifts 2026 EPS outlook after Q1 revenue and cash-flow gains - Stock Titan
Bioventus: Q1 Earnings Snapshot - marketscreener.com
Bioventus Reports First Quarter Financial Results - The Manila Times
Bioventus turns a profit in Q1 and pays down $22M of debt - Stock Titan
Should Value Investors Buy Bioventus (BVS) Stock? - Yahoo Finance
Bioventus Shareholder Notice - TMX Newsfile
Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year? - Yahoo Finance Australia
Bioventus Inc. (NASDAQ:BVS) Given Average Rating of "Buy" by Brokerages - MarketBeat
Earnings Preview: Bioventus to Report Financial Results Pre-market on May 06 - Moomoo
Bioventus Q1 Earnings: Can It Sustain Momentum After a Strong 2025? - BriefGlance
Bioventus schedules May 6 earnings release, 8:30 a.m. call - Stock Titan
(BVS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
CCORF Maintains Bioventus(BVS.US) With Buy Rating, Maintains Target Price $15 - Moomoo
Bioventus Deadline Alert - TMX Newsfile
BVS Earnings History & Surprises | EPS & Revenue Results | BIOVENTUS INCA (NASDAQ:BVS) - ChartMill
Bioventus Inc. ($BVS) CEO 2025 Pay Revealed - Quiver Quantitative
Bioventus (NASDAQ: BVS) sets 2026 virtual meeting, director slate and auditor vote - Stock Titan
Bioventus Inc. Class A Common Stock (BVS) Stock Price Today & Analysis - Gotrade
Bioventus (BVS) Stock: Buy or Sell? (Technical Strength) 2026-04-18Strong Buy Rating - Newser
Strength seen in Bioventus (BVS): Can its 6.6% jump turn into more strength? - MSN
Strength Seen in Bioventus (BVS): Can Its 6.6% Jump Turn into More Strength? - Yahoo Finance
Unaccepted RSU grant corrected for Bioventus (NASDAQ: BVS) director - Stock Titan
Bioventus (BVS) director amends filing on unaccepted 9,000 RSU grant - Stock Titan
Bioventus (BVS) CFO exercises 13,000 RSUs and withholds 5,648 shares for tax - Stock Titan
[Form 4] Bioventus Inc. Insider Trading Activity - Stock Titan
Bioventus (BVS) SVP gains 9,925 shares from RSU vesting, with tax withholding - Stock Titan
Bioventus (NASDAQ:BVS) Hits New 1-Year HighWhat's Next? - MarketBeat
(BVS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Are Investors Undervaluing Bioventus (BVS) Right Now? - Yahoo Finance
Aug Movers: Is Bioventus Inc stock showing strong momentumRecession Risk & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Is Bioventus (BVS) Stock in a Downtrend | Price at $9.04, Down 0.22%Volume Leaders - Cổng thông tin điện tử tỉnh Lào Cai
JPMorgan Chase Trims Stake in Bioventus Inc. - National Today
JPMorgan Chase & Co. Cuts Stock Position in Bioventus Inc. $BVS - MarketBeat
Bone Growth Stimulator Market size to exceed $2.83 Billion - openPR.com
Momentum Shift: Is Bioventus Inc stock showing strong momentum2026 Market Outlook & AI Driven Stock Reports - baoquankhu1.vn
Stop Loss: Is Bioventus Inc exposed to currency risksEarnings Risk Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Bioventus Inc. (NASDAQ:BVS) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Investor Mood: Is Bioventus Inc exposed to currency risksWeekly Profit Recap & Safe Capital Growth Tips - baoquankhu1.vn
BVS.O Technical Analysis & Stock Price Forecast - Intellectia AI
BVS Should I Buy - Intellectia AI
BVS.O PE Ratio & Valuation, Is BVS.O Overvalued - Intellectia AI
BVS.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
BVS News & Events - Intellectia AI
(BVS) Risk Channels and Responsive Allocation - Stock Traders Daily
Surprises Report: Is Bioventus Inc in a bullish channel2026 Gainers & Daily Technical Stock Forecast Reports - baoquankhu1.vn
BVS PE Ratio & Valuation, Is BVS Overvalued - Intellectia AI
CJS Securities Initiates Coverage on Bioventus (NASDAQ:BVS) - Defense World
BVS Technical Analysis & ETF Price Forecast - Intellectia AI
What is market pressure on Bioventus (BVS) Stock | Price at $9.06, Up 0.06%Community Momentum Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Bioventus (BVS) CFO vests 18,625 RSUs with 8,091 shares withheld for taxes - Stock Titan
(BVS) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Bioventus Inc.(NasdaqGS: BVS) added to S&P Healthcare Equipment Select Industry Index - marketscreener.com
0.76%
0.72%
자본화:
|
볼륨(24시간):